...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer

narmac, I don't know of any other penny biotech stock with eleven ongoing clinical trials!

No matter what, there is some hope here.

As I see it, a new share public offering for Zenith is warranted. 


Koo (IMO)

 

Share
New Message
Please login to post a reply